APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transdermal Drug Industry Growth and Trends Forecast to 2032

26 December 2025113 pages

Choose your research edition.

Industry ResearchTransdermal Drug Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Transdermal Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Transdermal Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transdermal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transdermal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Drug include Johnson & Johnson, Novartis, Mylan, GSK, Beijing Tide Pharmaceutical, Bayer, UCB Pharma, Teva Pharmaceutical and Nitto Denko, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transdermal Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Drug market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Drug Market by Company

Johnson & Johnson

Novartis

Mylan

GSK

Beijing Tide Pharmaceutical

Bayer

UCB Pharma

Teva Pharmaceutical

Nitto Denko

Mundipharma

Luye Pharma Group

IBSA Group

Hisamitsu Pharmaceutical

Grünenthal

Dr Reddy’s Laboratories

Chattem

Transdermal Drug Segment by Type

Methyl Salicylate-based Patch

Diclofenac Patch

Nicotine Transdermal Patch

Lidocaine Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Others

Transdermal Drug Segment by Application

Rx Channel

OTC Channel

Transdermal Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transdermal Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Methyl Salicylate-based Patch Table 2. Major Company of Diclofenac Patch Table 3. Major Company of Nicotine Transdermal Patch Table 4. Major Company of Lidocaine Patch Table 5. Major Company of Rivastigmine Transdermal Patch Table 6. Major Company of Fentanyl Transdermal Patch Table 7. Major Company of Others Table 8. Global Transdermal Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 10. Global Transdermal Drug Sales Market Share in Volume by Type (2021-2026) Table 11. Global Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 12. Global Transdermal Drug Sales Market Share in Value by Type (2021-2026) Table 13. Global Transdermal Drug Price by Type (2021-2026) & (US$/Pcs) Table 14. Global Transdermal Drug Sales by Type (2027-2032) & (M Pcs) Table 15. Global Transdermal Drug Sales Market Share in Volume by Type (2027-2032) Table 16. Global Transdermal Drug Sales by Type (2027-2032) & (US$ Million) Table 17. Global Transdermal Drug Sales Market Share in Value by Type (2027-2032) Table 18. Global Transdermal Drug Price by Type (2027-2032) & (US$/Pcs) Table 19. North America Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 20. North America Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 22. Europe Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 24. Asia-Pacific Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 26. Latin America Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Transdermal Drug Sales by Type (2021-2026) & (M Pcs) Table 28. Middle East and Africa Transdermal Drug Sales by Type (2021-2026) & (US$ Million) Table 29. Transdermal Drug Industry Trends Table 30. Transdermal Drug Industry Drivers Table 31. Transdermal Drug Industry Opportunities and Challenges Table 32. Transdermal Drug Industry Restraints Table 33. Global Transdermal Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Transdermal Drug Revenue Market Share by Company (2021-2026) Table 35. Global Transdermal Drug Sales by Company (2021-2026) & (M Pcs) Table 36. Global Transdermal Drug Sales Share by Company (2021-2026) Table 37. Global Transdermal Drug Market Price by Company (2021-2026) & (US$/Pcs) Table 38. Global Transdermal Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Transdermal Drug Major Company Production Sites and Headquarters Table 40. Global Transdermal Drug Company, Product Type & Application Table 41. Global Transdermal Drug Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Transdermal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Transdermal Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Transdermal Drug Sales by Region (2021-2026) & (M Pcs) Table 46. Global Transdermal Drug Sales Market Share in Volume by Region (2021-2026) Table 47. Global Transdermal Drug Sales by Region (2021-2026) & (US$ Million) Table 48. Global Transdermal Drug Sales Market Share in Value by Region (2021-2026) Table 49. Global Transdermal Drug Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 50. Global Transdermal Drug Sales by Region (2027-2032) & (M Pcs) Table 51. Global Transdermal Drug Sales Market Share in Volume by Region (2027-2032) Table 52. Global Transdermal Drug Sales by Region (2027-2032) & (US$ Million) Table 53. Global Transdermal Drug Sales Market Share in Value by Region (2027-2032) Table 54. Global Transdermal Drug Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 55. Global Transdermal Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 57. Global Transdermal Drug Sales Market Share in Volume by Application (2021-2026) Table 58. Global Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 59. Global Transdermal Drug Sales Market Share in Value by Application (2021-2026) Table 60. Global Transdermal Drug Price by Application (2021-2026) & (US$/Pcs) Table 61. Global Transdermal Drug Sales by Application (2027-2032) & (M Pcs) Table 62. Global Transdermal Drug Sales Market Share in Volume by Application (2027-2032) Table 63. Global Transdermal Drug Sales by Application (2027-2032) & (US$ Million) Table 64. Global Transdermal Drug Sales Market Share in Value by Application (2027-2032) Table 65. Global Transdermal Drug Price by Application (2027-2032) & (US$/Pcs) Table 66. North America Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 67. North America Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 69. Europe Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 71. Asia-Pacific Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 73. Latin America Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Transdermal Drug Sales by Application (2021-2026) & (M Pcs) Table 75. Middle East and Africa Transdermal Drug Sales by Application (2021-2026) & (US$ Million) Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Transdermal Drug Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. Novartis Transdermal Drug Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. Mylan Transdermal Drug Product Portfolio Table 90. Mylan Recent Development Table 91. GSK Company Information Table 92. GSK Business Overview Table 93. GSK Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 94. GSK Transdermal Drug Product Portfolio Table 95. GSK Recent Development Table 96. Beijing Tide Pharmaceutical Company Information Table 97. Beijing Tide Pharmaceutical Business Overview Table 98. Beijing Tide Pharmaceutical Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 99. Beijing Tide Pharmaceutical Transdermal Drug Product Portfolio Table 100. Beijing Tide Pharmaceutical Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 104. Bayer Transdermal Drug Product Portfolio Table 105. Bayer Recent Development Table 106. UCB Pharma Company Information Table 107. UCB Pharma Business Overview Table 108. UCB Pharma Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 109. UCB Pharma Transdermal Drug Product Portfolio Table 110. UCB Pharma Recent Development Table 111. Teva Pharmaceutical Company Information Table 112. Teva Pharmaceutical Business Overview Table 113. Teva Pharmaceutical Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 114. Teva Pharmaceutical Transdermal Drug Product Portfolio Table 115. Teva Pharmaceutical Recent Development Table 116. Nitto Denko Company Information Table 117. Nitto Denko Business Overview Table 118. Nitto Denko Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 119. Nitto Denko Transdermal Drug Product Portfolio Table 120. Nitto Denko Recent Development Table 121. Mundipharma Company Information Table 122. Mundipharma Business Overview Table 123. Mundipharma Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 124. Mundipharma Transdermal Drug Product Portfolio Table 125. Mundipharma Recent Development Table 126. Luye Pharma Group Company Information Table 127. Luye Pharma Group Business Overview Table 128. Luye Pharma Group Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 129. Luye Pharma Group Transdermal Drug Product Portfolio Table 130. Luye Pharma Group Recent Development Table 131. IBSA Group Company Information Table 132. IBSA Group Business Overview Table 133. IBSA Group Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 134. IBSA Group Transdermal Drug Product Portfolio Table 135. IBSA Group Recent Development Table 136. Hisamitsu Pharmaceutical Company Information Table 137. Hisamitsu Pharmaceutical Business Overview Table 138. Hisamitsu Pharmaceutical Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 139. Hisamitsu Pharmaceutical Transdermal Drug Product Portfolio Table 140. Hisamitsu Pharmaceutical Recent Development Table 141. Grünenthal Company Information Table 142. Grünenthal Business Overview Table 143. Grünenthal Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 144. Grünenthal Transdermal Drug Product Portfolio Table 145. Grünenthal Recent Development Table 146. Dr Reddy’s Laboratories Company Information Table 147. Dr Reddy’s Laboratories Business Overview Table 148. Dr Reddy’s Laboratories Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 149. Dr Reddy’s Laboratories Transdermal Drug Product Portfolio Table 150. Dr Reddy’s Laboratories Recent Development Table 151. Chattem Company Information Table 152. Chattem Business Overview Table 153. Chattem Transdermal Drug Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 154. Chattem Transdermal Drug Product Portfolio Table 155. Chattem Recent Development Table 156. North America Transdermal Drug Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 157. North America Transdermal Drug Sales by Country (2021-2026) & (M Pcs) Table 158. North America Transdermal Drug Sales Market Share by Country (2021-2026) Table 159. North America Transdermal Drug Sales Forecast by Country (2027-2032) & (M Pcs) Table 160. North America Transdermal Drug Sales Market Share Forecast by Country (2027-2032) Table 161. North America Transdermal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Transdermal Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Transdermal Drug Market Share by Country (2021-2026) Table 164. North America Transdermal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Transdermal Drug Market Share Forecast by Country (2027-2032) Table 166. Europe Transdermal Drug Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 167. Europe Transdermal Drug Sales by Country (2021-2026) & (M Pcs) Table 168. Europe Transdermal Drug Sales Market Share by Country (2021-2026) Table 169. Europe Transdermal Drug Sales Forecast by Country (2027-2032) & (M Pcs) Table 170. Europe Transdermal Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Transdermal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Transdermal Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Transdermal Drug Market Share by Country (2021-2026) Table 174. Europe Transdermal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Transdermal Drug Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Transdermal Drug Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Transdermal Drug Sales by Country (2021-2026) & (M Pcs) Table 178. Asia-Pacific Transdermal Drug Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Transdermal Drug Sales Forecast by Country (2027-2032) & (M Pcs) Table 180. Asia-Pacific Transdermal Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Transdermal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Transdermal Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Transdermal Drug Market Share by Country (2021-2026) Table 184. Asia-Pacific Transdermal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Transdermal Drug Market Share Forecast by Country (2027-2032) Table 186. Latin America Transdermal Drug Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 187. Latin America Transdermal Drug Sales by Country (2021-2026) & (M Pcs) Table 188. Latin America Transdermal Drug Sales Market Share by Country (2021-2026) Table 189. Latin America Transdermal Drug Sales Forecast by Country (2027-2032) & (M Pcs) Table 190. Latin America Transdermal Drug Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Transdermal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Transdermal Drug Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Transdermal Drug Market Share by Country (2021-2026) Table 194. Latin America Transdermal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Transdermal Drug Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Transdermal Drug Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Transdermal Drug Sales by Country (2021-2026) & (M Pcs) Table 198. Middle East and Africa Transdermal Drug Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Transdermal Drug Sales Forecast by Country (2027-2032) & (M Pcs) Table 200. Middle East and Africa Transdermal Drug Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Transdermal Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Transdermal Drug Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Transdermal Drug Market Share by Country (2021-2026) Table 204. Middle East and Africa Transdermal Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Transdermal Drug Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Transdermal Drug Distributors List Table 209. Transdermal Drug Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Transdermal Drug Image Figure 2. Global Transdermal Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Drug Sales (2021-2032) & (M Pcs) Figure 5. Methyl Salicylate-based Patch Image Figure 6. Global Methyl Salicylate-based Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. Diclofenac Patch Image Figure 8. Global Diclofenac Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Nicotine Transdermal Patch Image Figure 10. Global Nicotine Transdermal Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 11. Lidocaine Patch Image Figure 12. Global Lidocaine Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 13. Rivastigmine Transdermal Patch Image Figure 14. Global Rivastigmine Transdermal Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 15. Fentanyl Transdermal Patch Image Figure 16. Global Fentanyl Transdermal Patch Sales YoY Growth (2021-2032) & (M Pcs) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (M Pcs) Figure 19. Global Transdermal Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Transdermal Drug Market Share by Type 2025 VS 2032 Figure 21. North America Transdermal Drug Sales Market Share in Volume by Type in 2025 Figure 22. North America Transdermal Drug Sales Market Share in Value by Type in 2025 Figure 23. Europe Transdermal Drug Sales Market Share in Volume by Type in 2025 Figure 24. Europe Transdermal Drug Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Transdermal Drug Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Transdermal Drug Sales Market Share in Value by Type in 2025 Figure 27. Latin America Transdermal Drug Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Transdermal Drug Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Transdermal Drug Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Transdermal Drug Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Transdermal Drug Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Rx Channel Image Figure 34. Global Rx Channel Sales YoY Growth (2021-2032) & (M Pcs) Figure 35. OTC Channel Image Figure 36. Global OTC Channel Sales YoY Growth (2021-2032) & (M Pcs) Figure 37. Global Transdermal Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Transdermal Drug Market Share by Application 2025 VS 2032 Figure 39. North America Transdermal Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Transdermal Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Transdermal Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Transdermal Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Transdermal Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Transdermal Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Transdermal Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Transdermal Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Transdermal Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Transdermal Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Transdermal Drug Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 50. North America Transdermal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Transdermal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Transdermal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Transdermal Drug Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 54. Europe Transdermal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Transdermal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Transdermal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Transdermal Drug Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 58. Asia-Pacific Transdermal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Transdermal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Transdermal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Transdermal Drug Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 62. Latin America Transdermal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Transdermal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Transdermal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Transdermal Drug Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 66. Middle East and Africa Transdermal Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Transdermal Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Transdermal Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Transdermal Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Transdermal Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Lidocaine Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Others
Applications
  • Rx Channel
  • OTC Channel
Companies covered
  • Johnson & Johnson
  • Novartis
  • Mylan
  • GSK
  • Beijing Tide Pharmaceutical
  • Bayer
  • UCB Pharma
  • Teva Pharmaceutical
  • Nitto Denko
  • Mundipharma
  • Luye Pharma Group
  • IBSA Group
  • Hisamitsu Pharmaceutical
  • Grünenthal
  • Dr Reddy’s Laboratories
  • Chattem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transdermal Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transdermal Drug Market by Type
  6. 1.3.1 Methyl Salicylate-based Patch
  7. 1.3.2 Diclofenac Patch
  8. 1.3.3 Nicotine Transdermal Patch
  9. 1.3.4 Lidocaine Patch
  10. 1.3.5 Rivastigmine Transdermal Patch
  11. 1.3.6 Fentanyl Transdermal Patch
  12. 1.3.7 Others
  13. 1.4 Global Transdermal Drug Market Size by Type
  14. 1.4.1 Global Transdermal Drug Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Transdermal Drug Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Transdermal Drug Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Transdermal Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Transdermal Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Transdermal Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Transdermal Drug Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Transdermal Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transdermal Drug Industry Trends
  2. 2.2 Transdermal Drug Industry Drivers
  3. 2.3 Transdermal Drug Industry Opportunities and Challenges
  4. 2.4 Transdermal Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transdermal Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Transdermal Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Transdermal Drug Price (2021-2026)
  4. 3.4 Global Transdermal Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Transdermal Drug Company, Product Type & Application
  7. 3.7 Global Transdermal Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Drug Tier 1, Tier 2, and Tier 3
4 Transdermal Drug Regional Status and Outlook
  1. 4.1 Global Transdermal Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transdermal Drug Historic Market Size by Region
  3. 4.2.1 Global Transdermal Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transdermal Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transdermal Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transdermal Drug Forecasted Market Size by Region
  7. 4.3.1 Global Transdermal Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transdermal Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transdermal Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Drug by Application
  1. 5.1 Transdermal Drug Market by Application
  2. 5.1.1 Rx Channel
  3. 5.1.2 OTC Channel
  4. 5.2 Global Transdermal Drug Market Size by Application
  5. 5.2.1 Global Transdermal Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Transdermal Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Transdermal Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Transdermal Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Transdermal Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Transdermal Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Transdermal Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Transdermal Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Transdermal Drug Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Transdermal Drug Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Transdermal Drug Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Transdermal Drug Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Beijing Tide Pharmaceutical
  26. 6.5.1 Beijing Tide Pharmaceutical Company Information
  27. 6.5.2 Beijing Tide Pharmaceutical Business Overview
  28. 6.5.3 Beijing Tide Pharmaceutical Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Tide Pharmaceutical Transdermal Drug Product Portfolio
  30. 6.5.5 Beijing Tide Pharmaceutical Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Transdermal Drug Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 UCB Pharma
  38. 6.7.1 UCB Pharma Company Information
  39. 6.7.2 UCB Pharma Business Overview
  40. 6.7.3 UCB Pharma Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 UCB Pharma Transdermal Drug Product Portfolio
  42. 6.7.5 UCB Pharma Recent Developments
  43. 6.8 Teva Pharmaceutical
  44. 6.8.1 Teva Pharmaceutical Company Information
  45. 6.8.2 Teva Pharmaceutical Business Overview
  46. 6.8.3 Teva Pharmaceutical Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Transdermal Drug Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Recent Developments
  49. 6.9 Nitto Denko
  50. 6.9.1 Nitto Denko Company Information
  51. 6.9.2 Nitto Denko Business Overview
  52. 6.9.3 Nitto Denko Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Nitto Denko Transdermal Drug Product Portfolio
  54. 6.9.5 Nitto Denko Recent Developments
  55. 6.10 Mundipharma
  56. 6.10.1 Mundipharma Company Information
  57. 6.10.2 Mundipharma Business Overview
  58. 6.10.3 Mundipharma Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mundipharma Transdermal Drug Product Portfolio
  60. 6.10.5 Mundipharma Recent Developments
  61. 6.11 Luye Pharma Group
  62. 6.11.1 Luye Pharma Group Company Information
  63. 6.11.2 Luye Pharma Group Business Overview
  64. 6.11.3 Luye Pharma Group Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Luye Pharma Group Transdermal Drug Product Portfolio
  66. 6.11.5 Luye Pharma Group Recent Developments
  67. 6.12 IBSA Group
  68. 6.12.1 IBSA Group Company Information
  69. 6.12.2 IBSA Group Business Overview
  70. 6.12.3 IBSA Group Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 IBSA Group Transdermal Drug Product Portfolio
  72. 6.12.5 IBSA Group Recent Developments
  73. 6.13 Hisamitsu Pharmaceutical
  74. 6.13.1 Hisamitsu Pharmaceutical Company Information
  75. 6.13.2 Hisamitsu Pharmaceutical Business Overview
  76. 6.13.3 Hisamitsu Pharmaceutical Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hisamitsu Pharmaceutical Transdermal Drug Product Portfolio
  78. 6.13.5 Hisamitsu Pharmaceutical Recent Developments
  79. 6.14 Grünenthal
  80. 6.14.1 Grünenthal Company Information
  81. 6.14.2 Grünenthal Business Overview
  82. 6.14.3 Grünenthal Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Grünenthal Transdermal Drug Product Portfolio
  84. 6.14.5 Grünenthal Recent Developments
  85. 6.15 Dr Reddy’s Laboratories
  86. 6.15.1 Dr Reddy’s Laboratories Company Information
  87. 6.15.2 Dr Reddy’s Laboratories Business Overview
  88. 6.15.3 Dr Reddy’s Laboratories Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr Reddy’s Laboratories Transdermal Drug Product Portfolio
  90. 6.15.5 Dr Reddy’s Laboratories Recent Developments
  91. 6.16 Chattem
  92. 6.16.1 Chattem Company Information
  93. 6.16.2 Chattem Business Overview
  94. 6.16.3 Chattem Transdermal Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chattem Transdermal Drug Product Portfolio
  96. 6.16.5 Chattem Recent Developments
7 North America by Country
  1. 7.1 North America Transdermal Drug Sales by Country
  2. 7.1.1 North America Transdermal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transdermal Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Transdermal Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transdermal Drug Market Size by Country
  6. 7.2.1 North America Transdermal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transdermal Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Transdermal Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transdermal Drug Sales by Country
  2. 8.1.1 Europe Transdermal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transdermal Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Transdermal Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transdermal Drug Market Size by Country
  6. 8.2.1 Europe Transdermal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transdermal Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transdermal Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transdermal Drug Sales by Country
  2. 9.1.1 Asia-Pacific Transdermal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transdermal Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transdermal Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transdermal Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Transdermal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transdermal Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transdermal Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transdermal Drug Sales by Country
  2. 10.1.1 South America Transdermal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transdermal Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Transdermal Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transdermal Drug Market Size by Country
  6. 10.2.1 South America Transdermal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transdermal Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Transdermal Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transdermal Drug Sales by Country
  2. 11.1.1 Middle East and Africa Transdermal Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transdermal Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transdermal Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transdermal Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Transdermal Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transdermal Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transdermal Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transdermal Drug Value Chain Analysis
  2. 12.1.1 Transdermal Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transdermal Drug Production Mode & Process
  7. 12.2 Transdermal Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transdermal Drug Distributors
  10. 12.2.3 Transdermal Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst